Tenon Medical, Inc. has reported its financial results for the fiscal year ending December 31, 2025, revealing a revenue increase of 20% to $3.9 million, up from $3.3 million in 2024. This growth is attributed to a higher volume of surgical procedures and the addition of revenue from the recently acquired SImmetry+ System. The company's gross profit also rose to $2.4 million, resulting in a gross margin of 60%, compared to 52% in the previous year. Despite this improvement, Tenon continues to face significant operating losses, reporting a net loss of $12.6 million for 2025, slightly better than the $13.7 million loss recorded in 2024.
In August 2025, Tenon expanded its product offerings by acquiring the assets of SiVantage, Inc. and SIMPL Medical, LLC, which included the SImmetry+ System. This acquisition is expected to enhance Tenon's market position in the sacroiliac joint fixation market, which is estimated to be significantly underserved. The company is focused on increasing adoption rates of its products, particularly The Catamaran System and the SImmetry+ System, which are designed for minimally invasive surgical procedures.
Operationally, Tenon reported a total of 26 employees as of March 2026, with plans to expand its workforce to support growth initiatives. The company has also been actively working on increasing its clinician base and training programs to drive product adoption. However, it faces challenges related to reimbursement from third-party payors, which could impact the adoption of its products. The company is currently evaluating its options to regain compliance with Nasdaq's minimum bid price requirement, as its stock has not maintained the required price of $1.00 per share.
Looking ahead, Tenon anticipates continued operating losses as it invests in research and development, sales, and marketing efforts. The company has raised approximately $4.3 million through the issuance of convertible promissory notes, which will help fund its operations through at least the next 12 months. However, management has expressed concerns about its ability to achieve profitability in the future, given the ongoing challenges in the medical device market and the need for additional capital to support its growth strategy.
About Tenon Medical, Inc.
Tenon Medical, Inc. develops minimally invasive surgical systems for sacroiliac joint fusion to treat lower back pain. Its flagship product, The Catamaran System, offers a novel, single-implant approach designed for safety, efficiency, and effective fusion. Serving the US market, the company targets spine and pelvic surgeons, emphasizing clinical evidence, regulatory compliance, and intellectual property to differentiate its innovative solutions in the orthopedic device industry.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.